Baxter Healthcare Corporation Drug Brevibloc Concentrate to be Discontinued

(FDA) -- Baxter Healthcare Corporation has made a decision to discontinue Brevibloc Concentrate (esmolol HCl) 250 mg/mL, 10 mL ampul (NDC 10019-025-18 for the pack and NDC 10019-025-73 for the ampul). Read Letter from Baxter (PDF).

MORE ON THIS TOPIC